The price of Invitae Corporation (NYSE:NVTA) shares last traded on Wall Street rose 8.85% to $1.23.
NVTA stock price is now -7.42% away from the 50-day moving average and -46.31% away from the 200-day moving average. The market capitalization of the company currently stands at $338.48M.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
In other news, Wen Yafei, Chief Financial Officer sold 43,452 shares of the company’s stock on May 16. The stock was sold for $86,600 at an average price of $1.99. Upon completion of the transaction, the Chief Financial Officer now directly owns 700,297 shares in the company, valued at $0.86 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 16, Chief Executive Officer Knight Kenneth D. sold 45,432 shares of the business’s stock. A total of $54,487 was realized by selling the stock at an average price of $1.20. This leaves the insider owning 1,671,610 shares of the company worth $2.06 million. Insiders disposed of 106,490 shares of company stock worth roughly $0.13 million over the past 1 year. A total of 1.00% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in NVTA stock. A new stake in Invitae Corporation shares was purchased by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) during the first quarter worth $11,408,000. ALTIUM CAPITAL MANAGEMENT LP invested $503,000 in shares of NVTA during the first quarter. In the first quarter, VERITION FUND MANAGEMENT LLC acquired a new stake in Invitae Corporation valued at approximately $288,000. VIRTU FINANCIAL LLC acquired a new stake in NVTA for approximately $281,000. TWO SIGMA INVESTMENTS, LP purchased a new stake in NVTA valued at around $191,000 in the second quarter. In total, there are 357 active investors with 72.90% ownership of the company’s stock.
A candlestick chart of Invitae Corporation (NYSE: NVTA) showed a price of $1.1400 on Tuesday morning. During the past 12 months, Invitae Corporation has had a low of $1.05 and a high of $9.00. The fifty day moving average price for NVTA is $1.3234 and a two-hundred day moving average price translates $2.2857 for the stock.
The latest earnings results from Invitae Corporation (NYSE: NVTA) was released for Mar, 2023. According to the Diagnostics & Research Company, earnings per share came in at -$0.37, beating analysts’ expectations of -$0.39 by 0.02. This compares to -$0.80 EPS in the same period last year. The company reported revenue of $117.36 million for the quarter, compared to $123.69 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -5.12 percent. For the current quarter, analysts expect NVTA to generate $120.77M in revenue.
Invitae Corporation(NVTA) Company Profile
Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women’s health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
Leave a Reply